📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFN?-driven acquired resistance in preclinical cancer models. (2023)

First Author: Wong CW

Attributed to: Regenerative medicine: instrumentation for flow cytometry and cell printing funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-023-41737-1

PubMed Identifier: 37752135

Publication URI: http://europepmc.org/abstract/MED/37752135

Type: Journal Article/Review

Volume: 14

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723